A Nanobody-Based and TGF-β-Resistant Claudin 18.2-Specific CAR-T Generates Effective and Durable Anti-Tumor Response: A Preclinical Study
MOLECULAR THERAPY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined